Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study.
Value Health
; 23(10): 1324-1331, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-33032776
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Health Care Costs
/
Anti-HIV Agents
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Value Health
Journal subject:
FARMACOLOGIA
Year:
2020
Document type:
Article
Country of publication:
United States